Human B-cell proliferation in response to recombinant interleukin 2 is not due to T-cell help. 1985

Lê thi Bich-Thuy, and H C Lane, and A S Fauci

Positively selected human B-cell suspensions with no detectable T cells and containing more than 99.5% B cells both at the initiation and termination of culture were shown to proliferate in response to interleukin 2 (IL-2) in a dose-dependent fashion. The lack of influence of residual T cells on this proliferative response was demonstrated in experiments where T cells were added back in increasing numbers to B-cell suspensions. No detectable enhancing effect on B-cell proliferation was noted when 2.5% T cells were purposely added back to culture, a proportion far in excess of that which might be expected to contaminate B-cell suspensions under the present methodology. In contrast, when 10% T cells were added back to B-cell cultures, an enhanced proliferation of B cells was observed suggesting that the lack of effect of lower numbers of T cells was due to their inefficiency in helping B-cell proliferation in response to IL-2. Therefore, it is concluded that highly purified IL-2 is capable of triggering human peripheral blood B cells to proliferate and that this proliferation is not due to T-cell help.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006041 Goats Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP. Capra,Capras,Goat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent

Related Publications

Lê thi Bich-Thuy, and H C Lane, and A S Fauci
January 1985, Immunology letters,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
October 1988, The Journal of experimental medicine,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
August 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
October 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
June 1986, Journal of immunology (Baltimore, Md. : 1950),
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
April 2017, The Journal of experimental medicine,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
October 1996, International immunology,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
September 1984, Cellular immunology,
Lê thi Bich-Thuy, and H C Lane, and A S Fauci
December 1989, European journal of immunology,
Copied contents to your clipboard!